BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18796245)

  • 1. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
    El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
    Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Zak J
    Wiad Lek; 2004; 57(7-8):337-42. PubMed ID: 15631188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
    Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
    Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
    Ek T; Mellander L; Andersson B; Abrahamsson J
    Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia.
    Moritake H; Kamimura S; Kojima H; Shimonodan H; Harada M; Sugimoto T; Nao-I N; Nunoi H
    Pediatr Blood Cancer; 2013 Feb; 60(2):329-31. PubMed ID: 22976937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report.
    Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
    Pediatr Blood Cancer; 2004 May; 42(5):416-20. PubMed ID: 15049012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Moritz B; Eder J; Meister B; Heitger A
    Med Pediatr Oncol; 2001 Feb; 36(2):283-9. PubMed ID: 11452936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of CD4+ and B-lymphocyte populations is not associated with severe infectious complications in children with acute lymphoblastic leukemia during maintenance.
    Kostaridou S; Polychronopoulou S; Psarra K; Kapsimali V; Parcharidou A; Katevas P; Papasteriades C; Haidas S
    Int J Hematol; 2004 Nov; 80(4):354-60. PubMed ID: 15615261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients.
    Wang Y; Li H; Song X; Qi K; Cheng H; Cao J; Shi M; Yan Z; Jing G; Pan B; Sang W; Wang X; Zhao K; Chen C; Chen W; Zheng J; Li Z; Xu K
    Int J Lab Hematol; 2021 Apr; 43(2):250-258. PubMed ID: 33112046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Mazur B; Szczepański T; Karpe J; Sońta-Jakimczyk D; Bubała H; Torbus M
    Leuk Res; 2006 Jan; 30(1):33-6. PubMed ID: 16039713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
    Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
    Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
    Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
    Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients.
    Eyrich M; Wiegering V; Lim A; Schrauder A; Winkler B; Schlegel PG
    Br J Haematol; 2009 Nov; 147(3):360-70. PubMed ID: 19694715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of lymphocyte surface markers in childhood acute lymphoblastic leukemia during maintenance chemotherapy].
    Sugita K; Kurosawa H; Sakakibara H; Eguchi M; Furukawa T
    Gan To Kagaku Ryoho; 1992 May; 19(5):659-64. PubMed ID: 1580639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia.
    Groot-Loonen JJ; Otten BJ; van t' Hof MA; Lippens RJ; Stoelinga GB
    Pediatrics; 1995 Oct; 96(4 Pt 1):693-5. PubMed ID: 7567332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia.
    Kremeike K; Juergens C; Alz H; Reinhardt D
    Klin Padiatr; 2015 Nov; 227(6-7):329-34. PubMed ID: 26457956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.